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Summary
 
In normal mice, major histocompatibility complex (MHC) proteins are bound to many differ-
ent peptides, derived from the proteins of their host. In the thymus, the diversity of this collec-
tion of MHC 
 
1
 
 peptide ligands allows thymocytes bearing many different T cell receptors
(TCRs) to mature by low avidity reactions between the MHC 
 
1
 
 peptide ligands and the thy-
mocyte TCRs. To investigate this problem, the selection of T cells specific for a well-studied
combination of MHC 
 
1
 
 peptide, IE
 
k
 
 
 
1
 
 moth cytochrome c 88–103 (MCC), was investigated.
Mice were created that expressed IE
 
k
 
 bound to a single peptide, either a variant of MCC in
which a critical TCR contact residue, 99K, was changed to A, or a variant of a mouse hemo-
globin 64–76 (Hb) peptide, 72A. IE
 
k
 
 bound to the MCC variant caused the clonal deletion of
some T cells specific for the IE
 
k
 
 
 
1
 
 MCC ligand; nevertheless, it also positively selected many T
cells that could react with this ligand. Some of the TCRs on the selected T cells were related to
those on cells from normal mice and some were not. IE
 
k
 
 bound to the Hb variant, on the other
hand, did not select any T cells which could react with IE
 
k
 
 
 
1
 
 MCC. These results demonstrate
that although positive selection is a partially degenerate event, the sequence of the peptide in-
volved in positive selection controls the selected repertoire.
 
M
 
any mysteries about the processes that drive thy-
mocyte positive and negative selection have recently
been solved. It is now known that thymocytes are selected
to mature based on low avidity reactions between the 
 
a
 
/
 
b
 
TCRs they bear and combinations of MHC protein and
peptide in the thymus cortex (1–6). Reactions that are of
too high avidity cause thymocytes to die by clonal deletion
(7). Likewise, reactions that are of too low avidity also
cause thymocytes to die, in this case of neglect.
Thymocytes bearing a particular TCR can be positively
selected by a particular MHC protein bound to a number of
different peptides (2–4, 8). Also, a particular MHC 
 
1
 
 pep-
tide combination can positively select thymocytes bearing
many different TCRs (9–13). Perhaps these degeneracies
are due to the fact that many different TCR and MHC 
 
1
 
peptide combinations can achieve the affinity and concen-
trations necessary to reach the avidity of reaction required
for positive selection.
Positive selection is not a completely degenerate phe-
nomenon, however. Some peptides bound to a certain MHC
protein cannot select thymocytes bearing a particular TCR,
even though another peptide bound to the same MHC can
manage this (2–4, 14, 15). Likewise, a single MHC 
 
1
 
 pep-
tide combination probably does not select thymocytes bear-
ing as diverse a collection of TCRs as does the same MHC
protein bound to the 2,000 or more peptides with which it
is engaged in normal thymuses (9–13). The first experi-
ments done on this subject suggested that the selecting pep-
tide might be related in structure to the peptide that would
later be able to drive a productive response by a T cell
bearing a particular TCR (2–4). Later experiments indi-
cated that this view was too extreme and that the selecting
and activating peptides might not have to be obviously re-
lated (8, 15, 16). Some of these experiments were limited,
however, by the fact that they were done in vitro using
TCR transgenic thymocytes; thus, only a few different TCRs
could be tested. Also, most of the experiments involved se-
lection on class I MHC and few involved selection on class II.
To address this problem, we created a collection of mice
in which almost all class II proteins of a particular type were
occupied by a single peptide (11). The current experiments
were done to find out whether the TCR repertoire se-
lected by a single MHC 
 
1
 
 peptide combination would be
related to that selected by the same MHC bound to the
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many mouse peptides with which it is engaged in normal
mice. We chose to study a T cell specificity which has been
very well examined in normal mice, that of T cells specific
for the moth cytochrome c peptide 88–103 (MCC)
 
1
 
 bound
to IE
 
k
 
 (17–21). We found that IE
 
k
 
 bound to a variant of
MCC in which a central TCR contact residue (22), 99K,
had been exchanged for an A selected T cells which could
react with IE
 
k
 
 
 
1
 
 MCC and which bore TCRs which were
closely related in sequence to those selected in normal mice
by IE
 
k
 
 bound to mouse peptides.
 
Materials and Methods
 
Construction of Transgenes.
 
We have previously described the
production of genes coding for soluble IE
 
b
 
k
 
 covalently linked via
a flexible linker at its NH
 
2
 
-terminal end to several peptides that
can bind to intact IE
 
k
 
 protein (23). Two of these constructs, cod-
ing for IE
 
b
 
k
 
 bound to MCC with a substitution of A for K at po-
sition 99 (99A) or for mouse hemoglobin 
 
b
 
d
 
 64–76 (Hb) with a
substitution of A for N at position 72 (72A) were modified for in-
jection into mice. Modifications included the removal of the throm-
bin sites from the flexible linkers that bound the peptide to the
IE
 
b
 
k
 
 protein and introduction of genetic material coding for
wild-type IE
 
b
 
k
 
 transmembrane and cytoplasmic domains (gift of
Dr. H. Fischer). These genes were cloned into a plasmid (DOI)
containing a promoter from IE
 
a
 
 (gift of Drs. D. Mathis and C.
Benoist, I.G.B.M.C. Strasbourg France; reference 24). cDNA
coding for IE
 
a
 
d
 
 (gift of Dr. R. Germain, NIAID, NIH) was also
introduced separately into DOI as was cDNA coding for the
wild-type IE
 
b
 
k
 
 protein without covalently linked peptides. The
 
a
 
 chain construct was prepared for injection by digestion with
HhaI; the 
 
b
 
 chain constructs were cut with XbaI and NruI, and
the fragments were purified by electrophoresis and on glass beads
before injection.
 
Mice.
 
B10.BR and B10.M mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). All other animals were
bred in the Animal Care Facility at the National Jewish Medical
and Research Center (Denver, CO).
Transgenic mice were produced by injection of the 
 
IE
 
a
 
 gene
together with one of the 
 
IE
 
k
 
b
 
 genes into fertilized B10.M eggs.
Mice were screened for expression of the transgenes by the ability
of their peripheral blood cells to stimulate T cell hybridomas spe-
cific for IE
 
k
 
 bound to the covalently linked peptides, KC99A-4.18
for the 99A transgene and KH-8.3 for the 72A transgene or, for
the wild type IE
 
k
 
 transgene, by stimulation of KH-8.3 after addi-
tion of Hb peptide.
One founder mouse of each strain was crossed with animals
lacking invariant chain, IiKO, gift of Drs. E. Bikoff and R. Ger-
main (25). The F1 mice were crossed and F2 animals selected for
further breeding based on their expression of the IE transgene,
lack of expression of Ii, expression of H2
 
f
 
, and lack of expression
of H2
 
b
 
. Progeny for breeding were also selected, by measuring
the percentage of CD4
 
1
 
 V
 
b
 
3
 
1
 
 T cells they contained, for ab-
sence of either of the 129/J-derived mouse mammary tumor vi-
ruses that produce superantigens known to delete mouse T cells
bearing V
 
b
 
3. 129/Js are, of course, the originators of the Ii defi-
ciency. This last selection was very important for subsequent ex-
periments because the TCR repertoire to be examined was that
for IE
 
k
 
 bound to MCC, a TCR repertoire that is rich in T cells
bearing V
 
b
 
3 (17–21). Therefore, unless otherwise stated, all the
transgenic mice used in this study had genotypes that were
transgene
 
1
 
, H2
 
f
 
1
 
, H2
 
b
 
2
 
, IiKO and negative for superantigens
which react with V
 
b
 
3.
 
Antibodies and Flow Cytometry.
 
Single cell suspensions from
thymus or lymph nodes or spleen were filtered through nylon mesh
(Falcon, Becton Dickinson, Franklin Lakes, NJ), washed in bal-
anced salts solution (BSS) and stained with antibodies at 1–3 
 
3
 
10
 
7
 
 cells/ml in staining buffer (BSS, 0.1% sodium azide, 2% fetal
bovine serum). Before analysis for class II MHC expression, thy-
mus cells were enriched for large cells with a low speed spin, 500 
 
g
 
for 2 min, after which supernatant cells were discarded.
Cells were stained and analyzed for expression of TCR V
 
a
 
,
V
 
b
 
, CD4, and CD8 as previously described (26). Expression of
the IE
 
k
 
 transgenes was evaluated using biotinylated 14-4-4. The
biotinylated, fluorosceinated, or phycoerythrin labeled antibodies
were prepared in our laboratory or purchased from PharMingen
Corp. (San Diego, CA). Streptavidin conjugated to fluoroscein,
phycoerythrin, or cychrome was also purchased from PharMingen
Corp. Cells were incubated for 30 min at room temperature with
the primary antibody in the presence of 10% normal mouse se-
rum and a 10% culture supernatant of the anti-Fc receptor anti-
body 2.4G2 (27) to block nonspecific binding. Cells were then
washed three times before the addition of the secondary reagents
and then incubated with these materials at 4
 
8
 
C for 30 min. Cells
were then washed and staining profiles analyzed on a FACScan
 
Ò
 
instrument (Beckton Dickinson Inc., Mountain View, CA). At least
10
 
4
 
 cells were analyzed for each assay. Analysis of anti-IE
 
k
 
 staining
of thymus stromal cells was accomplished by gating on the cells in
the thymus with the largest forward and side scatter values as pre-
viously described (11).
 
Production of Chimeric Mice.
 
8–12-wk-old mice were irradi-
ated with 950 rads from a 
 
137
 
Cs source and immediately after-
wards reconstituted with fetal liver cells from 7–8 pooled day 14
fetuses, the progeny of the cross of two IE
 
k
 
 wild-type (wt) Ii
 
1
 
/
 
2
 
mice. Therefore, the majority of donors expressed Ii and the
IE
 
k
 
wt transgene without covalently bound peptides. Mice were
maintained on acidified chlorinated water and immunized with
antigen 8 wk later.
 
Production and Analysis of Antigen-specific T Cell Hybridomas.
 
Chimeric and normal mice were primed with MCC in complete
Freund’s adjuvant in the base of the tail. T cell hybridomas were
prepared from these animals as previously described (28). In brief,
lymph node cells were harvested from the draining nodes of the
immunization 7 d later. The cells were incubated for 4 d with
MCC and then live cells were purified and cultured for 3 more d
with saturating amounts of IL-2. The live cells were then fused to
an 
 
a
 
2
 
b
 
2
 
 variant of BW5147, BW
 
a
 
2
 
b
 
2
 
 (28). Hybridomas were
assayed for their ability to react with IE
 
k
 
 in the presence or ab-
sence of added MCC. Presenting cells were B10.BR spleen cells
which express IE
 
k
 
 at high levels, or cells from IEwt transgenic
mice, which express IE
 
k
 
 at low levels (Fig. 1). All hybridomas
used for further analysis expressed high levels of TCR and CD4.
 
Results
 
Characterization of Transgenic Mice.
 
In the past, T cell
TCR repertoires for several peptides, including MCC and
Hb, presented by IE
 
k
 
, have been very well studied (17–21,
29). The T cells bearing these TCRs were all selected in the
 
1
 
Abbreviations used in this paper:
 
 Hb, mouse hemoglobin 64-76; Ii, invari-
ant chain; MCC, moth cytochrome c peptide 88–103; wt, wild-type. 
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thymus by reaction between their TCRs and IE
 
k
 
 bound to
one or more of the mouse peptides with which it is nor-
mally engaged in animals. We wished to compare these well-
known TCR repertoires with those that might be selected
by IE
 
k
 
 bound to a single peptide. To this end we created
transgenic mice expressing IE
 
k
 
 bound covalently to single
peptides and no other IE proteins. The peptides chosen
were related to those used in the previous repertoire studies
and were MCC with a substitution of A for K at position
99 or Hb with a substitution of A for N at position 72.
These altered peptides will be called 99A and 72A, respec-
tively, in this paper. Their sequences are shown in Table 1.
At the moment, mice that express IE transgenes and no
other class II proteins cannot be constructed. It is, however,
possible to breed mice that express transgenic IE proteins
and no other IE molecule. This is best done by introduc-
tion of IE
 
a
 
 and IE
 
b
 
 transgenes into H2
 
f
 
 or H2
 
q
 
 animals
since these two haplotypes do not have functional IE
 
a
 
 or
IE
 
b
 
 genes of their own (30). Therefore, the IE transgenes
described in this paper were injected into the fertilized eggs
of H2
 
f
 
 B10.M mice. As described in Materials and Meth-
ods, mice transgenic for IE
 
k
 
 bound covalently to 99A, or for
IE
 
k bound covalently to 72A, were identified by the ability
of their peripheral blood lymphocytes to stimulate T cell
hybridomas specific for the two IEk 1 peptide combina-
tions. Mice transgenic for IEk with no covalently attached
peptide were identified by the ability of their peripheral
blood cells to stimulate a T cell hybridoma, KH-8.3, after
addition of its target peptide, Hb.
We have previously shown that the presence of Ii caused
the removal of the covalently bound peptide from class II
in cells (11). To prevent this, each of the transgenic lines
was crossed with invariant chain deficient mice (IiKO) and
the progeny were intercrossed to produce animals which
were H2f homozygous IiKO and lacked the 129/J-derived
mouse mammary tumor viruses that code for superantigens
which delete thymocytes bearing Vb3.
These crosses produced three lines of animals, all H2f
and IiKO, and expressing IEwt or IEk covalently bound to
99A or 72A. The mouse lines were called IEwtTg, 99ATg,
and 72ATg, respectively. H2f IiKO animals lacking any
transgenes were called Tg2. A list of the mice used in this
paper, and their characteristics, is shown in Table 2.
Thymus and spleen cells from these animals were stained
to determine expression of the transgenes. As shown in Fig. 1,
99ATg mice expressed the product of the transgenes at
high levels on the large cells in its thymus. They also ex-
pressed high levels of the product on their spleen cells, al-
though not as many spleen cells in 99ATg mice were IEk1
as in control B10.BR animals. Levels approximated those
on the equivalent B10.BR H2k cells. 72ATg spleen cells
stained less well, and expression of this transgene was very
low in the thymus. Expression of the IEwt transgene was
very low on spleen cells, regardless of whether or not the
mice expressed Ii. The promoter used in these experi-
ments, although derived from the IEa gene itself, is known
to drive variable levels of expression of class II proteins in
transgenics (24). These results are probably manifestations
of this phenomenon.
To establish the distribution of IEk-bearing cells in the
thymuses of these mice, frozen sections of their thymuses
were stained with biotinylated anti-IEk and streptavidin-
coupled horseradish peroxidase. Biotinylated anti-IAb or
anti-Kk served as controls. As expected, both the cortex
and medulla of B10.BR thymuses stained brightly with the
anti-IEk reagent. No staining above background was ob-
served with the Tg2 or 72ATg thymuses, indicating that
expression of the transgene was very low on both cortical
and medullary epithelium in the latter mouse. Anti-IEk
stained the cortical epithelium of 99ATg animals almost as
brightly as it stained that of B10.BRs, with intense reticular
patterning. By contrast there was no staining above back-
ground in the medulla of the 99ATg animals. These results
demonstrated that the 99A transgene was well expressed
in  the cells responsible for positive selection of class II–
restricted T cells, thymus cortical epithelium, but poorly, if
at all, expressed on medullary thymus epithelium. T cell
tolerance to the transgene in 99ATg mice must be estab-
lished by contact with thymus cortical epithelium or bone
marrow–derived cells.
Staining experiments of this type did not reveal whether
or not the IE proteins in the 99ATg and 72ATg mice were
still bound to the covalent peptides with which they had
been engaged genetically. To find out whether displacement
with other peptides had occurred, cells from the transgenic
mice were tested for their ability to present exogenously
Table 1. Peptides Involved in these Experiments
Name Origin Sequence
72A Mouse Hbbd 64–76 72A GKKVITAFAEGLK
99A MCC 88–103 99A ANERADLIAYLAQATK
MCC MCC 88–103 ANERADLIAYLKQATK
Amino acids known to point into the IEk-binding cleft are underlined.
The amino acids which have been changed from the wild-type peptide
and the amino acid from which they were changed are boldfaced.
Table 2. Mice Used in these Experiments
Mouse Transgenes
Expression of
Class II Ii
B10.M None IAf Yes
Tg2 None IAf No
72ATg IEa 1 IEbk-72A IAf IEk-72A No
99ATg IEa 1 IEbk-99A IAf IEk-99A No
IEwtTg IEa 1 IEbk IAf IEk No
IEwtTg Ii1 IEa 1 IEbk IAf IEk Yes
B10.BR None IAf IEk Yes1444 Selection of Canonical TCRs by a Single MHC 1 Peptide
added peptides to T cells specific for IEk bound to the ex-
ogenous peptide. Thymus and spleen cells from the 99ATg
mice presented exogenous peptides very poorly (Fig. 2). By
contrast, thymus and spleen cells from the IEwtTg animals
presented peptide fairly well, and thymus and spleen cells
from B10.BR animals had very good activity.
Spleen and thymus cells from 72ATg mice presented ex-
ogenous antigen even less well than those of 99ATg ani-
mals (data not shown), indicating that the 72A peptide, like
the 99A peptide, was not displaced from the IEk molecule
in Ii2 animals.
These experiments demonstrated that virtually all of the
IEk molecules on the surfaces of 99ATg and 72ATg cells
were occupied by the 99A and 72A peptides, respectively.
Even though the IEwtTg cells bore only small amounts of
IEk on their surfaces as detected by staining, they still had
more IE molecules on their surfaces, which could present
exogenous peptides, than 99ATg cells did.
Cells Bearing Either of Two TCRs Specific for IEk 1 MCC
Are Deleted in 99ATgs. A number of mice have been pro-
duced that express TCR transgenes specific for IEk 1 MCC.
To find out whether the 99ATg or 72ATg mice could pos-
itively select thymocytes bearing these TCRs, mice ex-
pressing two of these TCRs, AD10 and AND (31), were
crossed with the 99ATg and 72ATg animals. Progeny (which
were still Ii1) were tested for expression of the TCR and
IE transgenes and for expression of H2k and H2f. They
were then tested for selection of the thymocytes bearing the
transgenic TCRs by estimation of the numbers of CD41
mature thymocytes bearing high levels of the relevant Va
and Vb regions, Va11 and Vb3.
The results in Fig. 3 show that CD41 thymocytes bear-
ing either of the two transgenes were selected with low ef-
ficiency in nontransgenic H2f homozygous mice. This was
not because H2f proteins caused deletion of thymocytes
bearing these TCRs since CD41 thymocytes bearing either
the AND or AD10 TCRs appeared in large numbers in
H2fxk mice, positively selected by the wild-type IEk protein 1
some unknown mouse peptide.
Figure 1. (A) IEk expression on transgenic thymus cells. Large cells from the thymuses of 72ATg and 99ATg and control B10.BR and Tg2 mice were
prepared and stained with anti-IEk as described in Materials and Methods. Here, the staining profile of thymus cells from the various mice overlaid on the
stained background control of Tg2 thymus cells. (B) IEk expression on transgenic spleen cells. Spleen cells from 72ATg, 99ATg, IEwtTg, and IEwtTg Ii1
mice and from control B10.BR and Tg2 animals were prepared and stained with anti-IEk as described in Materials and Methods. Here, the staining pro-
file of the spleen cells from the various types of mice overlaid on the stained background control of Tg2 spleen cells is shown. For both A and B, the re-
sults are representative of at least three independent experiments.
Figure 2. Thymus and spleen cells from 72ATg and 99ATg mice
present exogenous peptides poorly. Thymus and spleen cells were isolated
from various types of mice as described in Materials and Methods. They
were cultured with different concentrations of Hb and a T cell hybri-
doma, KH-8.3, specific for IEk 1 Hb. The ability of the cells to present
the exogenously added peptide was assayed by measurement of produc-
tion of IL-2 by the T cell hybridoma 24 h later. The results are represen-
tative of at least three independent experiments.
Figure 3. IEk-99A causes the clonal deletion of T cells bearing canoni-
cal IEk 1 MCC–reactive TCRs. Animals expressing the AND or AD10
TCR transgenes were crossed with 72ATg or 99ATg mice, and the ani-
mals were intercrossed such that some were H2fxk and others were H2f
homozygous. Thymocytes from these animals were stained with anti-
Va11, anti-Vb3, and CD4. The counts are those of cells/thymus-bearing
CD4 and high levels of Va11 and Vb3. The results shown are the aver-
ages of between one and three mice of each type.1445 Liu et al.
Introduction of the 99ATg did cause deletion, however,
as witnessed by the fact that mature CD41 T cells bearing
the transgenic TCRs were lower in number in H2fxk mice
that expressed the 99ATg than they were in animals of the
same MHC type that did not express the transgene. T cells
bearing the AD10 TCR have previously been reported to
be antagonized and deleted by very high concentrations of
MCC99A bound to IEk (32), so this result was not surpris-
ing. Thymocytes bearing the AND TCR were more effi-
ciently deleted in 99ATg mice than were thymocytes bear-
ing the AD10 TCR. The AND and AD10 TCRs differ by
a single amino acid. The AND TCR has an alanine residue
in its Va CDR3 region, four amino acids COOH terminal
to the invariant cysteine, whereas the AD10 TCR has a
threonine at this position (28). Apparently this change causes
the two TCRs to have slightly different affinities for IEk
bound to MCC 99A, resulting in different efficiencies of de-
letion of thymocytes bearing the two different TCRs.
These experiments were done with mice that still ex-
pressed Ii and hence the MCC99A peptide was probably
displaced from some of the 99ATg class II proteins in the
mice (11). Thus the fact that expression of the 99ATg in
H2f homozygous mice increased the numbers of mature
CD41 thymocytes bearing the AD10 TCR could not be
properly evaluated. It is possible that this indicated that the
99ATg could both positively and negatively select thy-
mocytes bearing this TCR, i.e., the affinity of AD10 for
IEk bound to 99A was in the marginal zone which has been
noted before for other TCR, MHC 1 peptide combina-
tions. Alternatively, positive selection in this case might
have been driven by interactions between the AD10 TCR
and 99ATg proteins from which the MCC99A peptide had
been displaced. Future experiments will resolve this.
Expression of the 72ATg did not affect the fate of the
thymocytes in any animal, suggesting either that this pro-
tein was not expressed at high enough levels to be effective
and/or that the AND and AD10 TCRs had no productive
affinity for this IEk–peptide combination.
These experiments showed that some TCRs specific for
IEk 1 MCC have a high enough affinity for IEk-99A to
cause thymocytes bearing them to be deleted in 99ATg
mice. Hence, the extent of the TCR repertoire for IEk 1
MCC in 99ATg mice is limited, not only by failure to pos-
itively select, but also by clonal deletion of the relevant
cells.
The 99ATg Selects T Cells that Can React with IEk 1
MCC. IiKO mice that express class II proteins covalently
bound to peptides that can occupy their grooves cannot be
primed with foreign proteins or peptides (data not shown).
Therefore, the ability of T cells from the class II–peptide
transgenic mice to react with foreign proteins or peptides
could not be evaluated in intact mice. To circumvent this
problem, the transgenic mice were irradiated and reconsti-
tuted with fetal liver from H2f animals transgenic for IEk-
wtTg genes and expressing Ii. In the chimeric animals that
were thus created, T cells were positively selected on host
thymus cortical epithelial cells, and could be primed with
foreign peptides presented on the IEkwt expressing fetal
liver derived cells. The T cells must also have been tolerant
to the low levels of IEk bound to mouse peptides expressed
on IEkwt Ii1 and Ii2 cells.
Three types of chimeric mice were produced in which
the hosts were 99ATg, 72ATg, or Tg2. After T cells had
matured in the chimeras, they were primed with MCC pep-
tide and the primed T cells were harvested and converted
into T cell hybridomas as described in Materials and Meth-
ods. As additional controls, hybridomas were also produced
in the same fashion from MCC primed, nonchimeric H2f
mice with or without Ii expression, and from nonchimeric
IEwtTg mice with or without Ii expression.
Hybridomas were tested for their ability to respond to
B10.BR, IEwtTg Ii1, or 99ATg spleen cells. Examples of
the reactivities of some of the hybridomas from 99ATg
chimeric mice are shown in Fig. 4. None of the hybri-
domas responded to IEwtTg Ii1 or 99ATg cells. Thus the
hybridomas were tolerant to class II proteins at the levels
they were expressed in the chimeric mice. Several of the
hybridomas did, however, respond to B10.BR spleen cells.
Anti-IE addition to the stimulation cultures showed that
this was due to reaction with IEk (data not shown). The
parent T cells for these hybridomas must have been tolerant
to IEk bound to the mouse peptides with which it is nor-
mally engaged at the very low levels at which it was ex-
pressed in the chimeric animals (Fig. 1), but were not toler-
ant to the same combination of IEk and peptides at the high
levels at which it is expressed on B10.BR cells. These hy-
bridomas were probably another example of the fact that
selection on a particular MHC–peptide combination causes
cells to mature, which are likely to react with that same
MHC protein bound to other peptides, particularly when
expressed at high levels (11–13).
The hybridomas were also tested for their ability to re-
spond to different concentrations of MCC presented by
B10.BR cells (Fig. 5). Many of the hybridomas responded
well to this antigen and were as sensitive to low doses of
Figure 4. Some IEk 1 MCC–reactive T cells from 99ATg mice react
with IEk 1 normal mouse peptides. T cell hybridomas specific for IEk 1
MCC were prepared from 99ATg animals as described in Materials and
Methods and were assayed for their ability to respond to spleen cells from
various types of mice. The results shown are typical of two independent
experiments.1446 Selection of Canonical TCRs by a Single MHC 1 Peptide
the peptide as a typical hybridoma prepared from primed
T cells from a normal mouse. Some of the hybridomas, for
example KMAC-92, which responded to B10.BR cells in
the absence of peptide responded better when increasing
doses of MCC were added to the cultures.
The numbers of hybridomas obtained from two mice of
each type are shown in Table 3. When T cells cannot react
with the immunizing MHC 1 peptide combination, im-
munized lymph nodes give rise to few T cell blasts, and few
T cell hybridomas are produced (our unpublished observa-
tions). This was manifest in this experiment by the fact few
hybridomas were obtained from fusion of MCC-immu-
nized T cells from some of the mice that did not express an
IEk protein and Ii in their thymus stromal cells. Analysis of
the numbers of hybridomas that could react with IEk 1
MCC supported this conclusion. No hybridomas with this
specificity were obtained from mice which did not express
IEk on their thymus stromal cells. This included the Tg2
mice that contained fetal liver–derived cells expressing
IEwt and Ii. Hence, as previously reported, the MHC class
II proteins on the fetal liver–derived cells in these chimeras
could not participate in positive selection (33, 34).
No hybridomas that could react with IEk 1 MCC were
obtained from IEwtTg mice. Thus, either the peptides that
occupied the grooves of IEk in IiKO animals did not allow
selection of IEk 1 MCC–reactive T cells, or the levels of
IEk in these animals were too low to allow selection of such
cells (14). Also, no T cell hybridomas that could react with
IEk 1 MCC were obtained from 72ATg chimeric mice. This
might have been due either to an inability of IEk bound to
the 72A peptide to select such cells, or it may have been
due to the very low levels of expression of this combina-
tion in the thymuses of the transgenic animals. Some of the
hybridomas that were produced in the fusion of T cells
from 72ATg chimeric mice were specific for IAf bound to
MCC (data not shown). It is interesting that T cells with
this specificity were not produced from fusions of T cells
from mice that lacked an IEk transgene. Future experiments
will examine this phenomenon in more detail.
A number of hybridomas specific for IEk 1 MCC were
obtained from 99ATg chimeric mice. These hybridomas
could not have been positively selected on the fetal liver–
derived cells in the chimeras since similar hybridomas did
not appear in the other chimeras prepared with the same
fetal liver. The results with primed B10.M or Tg2 mice
demonstrate that these hybridomas could not have been se-
lected on IAf. Finally, these hybridomas were not selected
on the small amounts of IEk on the 99ATg thymus epithe-
lial cells from which the 99A peptide had been displaced
since there were fewer of these proteins in 99ATg thy-
muses than there were in IEwtTg thymuses (see data in Fig.
2) and mice of the latter type failed to produce T cells with
this specificity. These controls proved that the T cell par-
ents of the IEk 1 MCC–reactive hybridomas obtained
from the chimeric 99ATg mice must have been positively
selected on the 99ATg.
IEk Bound to MCC99A Selects IEk 1 MCC–reactive T
Cells which Have TCRs Similar to those Selected by IEk in Nor-
mal Mice. The IEk 1 MCC–reactive T cell hybridomas
listed in Table 3 were stained with anti-Va and anti-Vb
antibodies. Table 4 lists the combinations found on these cells.
We were surprised to find that only about a quarter of the
hybridomas from IEwt Ii1 animals bore the pairing of
Va11 Vb3, which is usually associated with recognition of
IEk 1 MCC. Even though an overall analysis of this type
for responses to IEk 1 MCC 88–103 (in contrast to IEk 1
pigeon cytochrome C 88–104) is not available in the literature,
the impression is that almost all T cells in normal mice specific
for IEk 1 MCC bear Va11 and Vb3. Perhaps the difference
between the results in the literature and those reported here
is due to the low levels of IEk on the selecting thymus epi-
thelium in the IEwt Ii1 mice used in our experiments.
Clearly, T cells selected on IEk bound to 99A could bear
the same Va–Vb combinations, including Va11 and Vb3,
as those selected on IEk bound to many mouse peptides
(17–21).
Figure 5. IEk 1 MCC–specific T cells from 99ATg mice are as reac-
tive with their ligand as T cells from normal mice are. The response of
99ATg T cell hybridomas to IEk 1 MCC was compared with that of a
representative T cell hybridoma, 5KC-73.8/S1.6, from normal mice. The
results shown are typical of two independent experiments.
Table 3. IEk-99A Selects T Cells that Can React with IEk 1 
MCC
Mouse
IE on No. Hybridomas
Thymus
stroma
Fetal liver–
derived cells Tested
IEk 1
MCC Rx
IEwt Ii1/2®Tg2 None IEwt 6 0
IEwt Ii1/2®72ATg 72A IEwt 92 0
IEwt Ii1/2®99ATg 99A IEwt 116 21*
B10.M None None 91 0
Tg2 None None 6 0
IEwt Ii1 IEwt Ii1 IEwt Ii1 126 66
IEwt IEwt IEwt 2 0
*Eight of these hybridomas had identical TCR a and b chain se-
quences.1447 Liu et al.
The receptors from the 99ATg chimera derived T cells
bearing Va11 and Vb3 or Vb8.3 were sequenced (Table 5
and 6). The TCR sequences from eight of the nine hybri-
domas bearing Va11 and Vb3 were identical. The T cell
parents of these cells must have come from the same ex-
panded clone. This result suggested that there were rela-
tively few IEk 1 MCC–specific T cells in the 99ATg chi-
meric mice since hybrids derived from a single clone are not
usually found in fusions to antigen specific T cells from nor-
mal mice (P. Marrack, personal observation).
Consensus sequences for the CDR3 regions of TCRs
specific for IEk 1 MCC and selected in normal IEk1 mice
were derived from the literature (17–21, 35; Tables 5 and 6).
Most of the a chain CDR3s of these TCRs used Va11.1,
had an E 3 amino acids COOH terminus to the conserved
C, and had CDR3s which were otherwise rich in compact
amino acids such as A and S. A notable exception to these
rules is the a chain of the well-known T cell hybridoma,
2B4, which uses Va11.2 and has a lengthier CDR3 (18, 20).
The literature suggests two different consensus sequences
for the CDRs of the TCR b chains. Both are shown in
Tables 5 and 6. Consensus sequence 1 was most commonly
reported in the past (17–21), with consensus sequence 2
derived from that of 2B4 and a collection of sequences from
mice expressing IEk and heterozygous for Ii expression (15).
The CDR3 sequences of the 99ATg T cells are also
shown in Tables 5 and 6. Like 2B4 and unlike the norm,
the two Vb3-bearing T cell hybridomas bore Va11.2.
Va11.1 in combination with Vb3 may cause a higher reac-
tivity for IEk 1 MCC99A than Va11.2 does since most of
the Va11.1-bearing, IEk 1 MCC reactive T cells from nor-
mal mice are activated or deleted by IEk 1 MCC99A, but
2B4 is not (21, 32, 35). Consequently, the Va11.1- and
Vb3-bearing T cells may have been deleted in 99ATg mice,
leaving as IEk 1 MCC–reactive T cells only those which
bore, with Vb3, Va11.2. The two Va11 family members
differ by only five amino acids (36). Only one of these
changes, position 72 in the CDR4 loop which is an R in
Va11.1 and S in Va11.2, maps to any region that might
contact MHC and peptide (37, 38). Perhaps the shorter,
uncharged side chain of the S in Va11.2 and/or the pres-
ence of bulky amino acids in the TCR a and b chains re-
duced contact between the TCR and IEk 1 99A, and thus
allowed IEk 1 MCC–reactive T cells bearing Va11.2 to be
positively selected and not deleted by the 99ATg.
Other than this, the a chain CDR3 sequences of the
Vb3- and Vb8.3-bearing IEk 1 MCC–reactive TCRs ob-
tained from 99ATg mice were similar in sequence and
length to the consensus with the exception that one lacked
the acidic amino acid usually found three residues COOH
terminus to the conserved cysteine, and was thus similar in
sequence to the CDR3 of a TCR reported to cross-react
between MCC and MCC99E (39), and two contained a
bulky aromatic amino acid.
The CDR3 sequences of the two Vb3-bearing TCRs ob-
tained from 99ATg mice were very similar in sequence to
that of consensus 2, the group which includes the 2B4 TCR
(Tables 5 and 6). As discussed above, this similarity may
have been driven by the requirement for a low reactivity
with IEk bound to MCC99A.
Table 4. Va and Vb Use by IEk 1 MCC–reactive T Cells
Selecting
IEk
Percentage (No.) of IEk 1 MCC–reactive T cells using:
Va11/Vb3V a 11/Vb8V a 11/Other Vb Other Va/Vb
IEwt Ii1 26 (7) 11 (3) 26 (7) 37 (9)
99A 45 (9*) 10 (2) 40 (8) 5 (1)
T cell hybridomas were analyzed for Va and Vb expression as de-
scribed in Materials and Methods.
*Includes eight with identical TCRs.
Table 5. TCR a Chain Sequences
T cell
Selecting
CDR3 Ja IE Va
Consensus IEk 11.1 CAAEASS TNKLVFG –
2B4 IEk 11.2 CAALRVTGGNNKLTFG 47
KMAC-92* 99A 11.2 CAAGASS FNKLVFG 42
KMAC-19 99A 11.2 CAAEASG SWQLIFG 17
KMAC-75 99A 11.1 CAAEASN TNKVVFG 27
KMAC-126 99A 11.1 CAAEAAN NNAPRFG 27
Sequences of IEk 1 MCC–reactive TCRs from 99ATg mice. The
TCR a chain sequences of IEk 1 MCC–reactive T cells from 99ATg
mice are shown together with consensus sequences derived from the
literature (15, 17–21, 34).
*Identical sequences were found in seven other T cell hybridomas from
the same fusion.
Table 6. TCR b Chain Sequences
T cell
Selecting
CDR3 Ja IE Vb
Consensus 1 IEk 3 CASSLNNANSDYTFG 1.2
Consensus 2 IEk 3 CASSLNWGQDTQYFG 2.5
KMAC-92* 99A 3 CASSLNWGGDTQYFG 2.5
KMAC-19 99A 3 CASSLNWGGGEQYFG 2.6
KMAC-75 99A 8.3 CASSPGTGASDYTFG 1.2
KMAC-126 99A 8.3 CASSDAQNTGQLYFG 2.2
Sequences of IEk 1 MCC–reactive TCRs from 99ATg mice. The
TCR-b chain sequences of IEk 1 MCC–reactive T cells from 99ATg
mice are shown together with consensus sequences derived from the lit-
erature (15, 17–21, 34).
*Identical sequences were found in seven other T cell hybridomas from
the same fusion.1448 Selection of Canonical TCRs by a Single MHC 1 Peptide
The results in Tables 5 and 6 did suggest one other idea:
most of the TCR a and b chains which could contribute to
TCRs that could react with IEk 1 MCC might now be
known. Thus, several of the sequences from the 99ATg
mice were identical to sequences that had already been de-
scribed. The a chain of KMAC-75 was identical to that of
a previously described hybridoma, 5C.C7 (20). The a chain
CDR3 sequence of KMAC-19 was identical to that previ-
ously reported for a TCR selected on wild-type IEk in Ii1/2
mice (15). This previous publication did not mention
whether the TCR in question bore Va11.1 or Va11.2.2.
Likewise, the b chain sequence of KMAC-19 was identical
to that previously described for a T cell selected by IEk
bound to MCC (15).
Discussion
The complete repertoire of T cells selected on the
99ATg and specific for IEk 1 MCC was not assessed in this
paper since the T cells we isolated came from mice that
contained fetal liver cells bearing IEk engaged by normal
mouse peptides, albeit at low levels. The T cells in the chi-
meras were thus positively selected by IEk bound to a single
peptide, and were tolerant to IEk bound to many normal
mouse peptides at low levels, but not necessarily at high
levels. This was manifested by the fact that none of the T
cell hybridomas obtained from the chimeras reacted with IEk
on IEwtTg Ii1 cells, although some of the hybridomas did
react with IEk on B10.BR cells. Nevertheless, it is likely that
expression of even the low levels of IEk found in the chi-
meras did cause deletion of some IEk 1 mouse peptide–
reactive T cells, and thus reduce the total diversity of TCRs
found in the chimeras. Moreover, all the mice contained an
additional class II protein, IAf, and it is likely that at least
some selected T cells were deleted by recognition of this
protein, bound to its array of mouse peptides (11).
Assessment of the ability of IEk bound to 99A to select
IEk 1 MCC–reactive T cells was also limited by the fact
that some TCRs specific for this latter ligand also react
with high affinity with the 99A selecting ligand (32). This
was demonstrated in this paper by the deletion in 99ATg
mice of T cells bearing the well known IEk 1 MCC reac-
tive TCRs, AND or AD10 (20, 31, 32).
Overall, therefore, the repertoire for IEk 1 MCC in the
transgenic chimeras was limited to some extent by negative
selection on two types of ligands, low levels of wild-type
IEk or IAf bound to mouse peptides, and IEk-99A.
In spite of these two limitations, it was clear that T cells
reactive with IEk 1 MCC could be positively selected by
IEk-99A, a closely related ligand. A previous publication
showed that MCC with substitutions of E for K at position
99, or E for T at position 102, and indeed even MCC itself
could positively select T cells reactive with IEk 1 MCC
(15). Assuming that the affinity/avidity hypothesis of posi-
tive selection is correct, these results show that TCRs with
high affinity for IEk 1 MCC can have an appropriate se-
lecting affinity for IEk 1 any of these MCC variants or
even for IEk 1 MCC itself at the concentrations that these
ligands were expressed in the thymus.
Selection is peptide specific. T cells specific for IEk 1
MCC cannot be selected by IEk bound to any peptide.
Such T cells were not positively selected in animals ex-
pressing IEk but not Ii (reference 14 and this paper). Appar-
ently none of the peptides that were bound to IEk in IiKO
animals could participate in selecting T cells that can react
with IEk 1 MCC. Also, as shown in this paper, IEk 1
MCC–reactive T cells were not obtained from animals ex-
pressing IEk bound to 72A. Likewise, T cells with this
specificity were not selected by IEk bound to a lambda re-
pressor peptide (15).
Our result with the 72A peptide is quite surprising since
it has previously been shown that unaltered Hb 67–76 could
select MCC-reactive T cells (15). The 72A peptide differed
from that previously used by the conservative change of
A for N at the central, T cell contact residue of the peptide,
and by a longer NH2-terminal tail protruding from the IEk-
binding groove. MCC itself has a basic amino acid, K, at
the equivalent position. Perhaps TCRs that will react with
MCC are selected better by Hb with the hydrophilic amino
acid N at this position than Hb with the shorter, more hy-
drophobic A. 99A, however, also has an A at the equiva-
lent position and, as shown in this paper, 99A selected
MCC-reactive TCRs well.
Alternatively or as well, perhaps the difference was due
to the level of expression of the IEk–peptide conjugates.
The IEk-99A transgenic protein was expressed at much
higher levels per cell than the IEk-72A conjugate. This may
have caused positive selection of thymocytes bearing TCRs
with very low affinity for the 99A peptide, whereas low af-
finity positive selection may not have been possible in the
72ATg mice. Recent measurement of the affinity of a
TCR on one of the IEk 1 MCC–specific T cells described
in this paper showed that it did indeed have extremely low
affinity for IEk-99A.
Finally, the difference may be due to the fact that the T
cells used in this paper were tolerant to IEwt and, less
likely, to IAf. Tolerance to IEk plus all the peptides to
which it is bound in normal mice may have deleted all the
T cells selected on IEk-72A that could react with IEk 1
MCC. We do not think this is the explanation, however,
because preliminary experiments with 72ATg T cells that
are not tolerant to IEwt suggest that these T cells are also
unable to react with IEk 1 MCC.
Some of the TCRs specific for IEk 1 MCC that were
positively selected in the 99ATg mice were quite similar to
those found in normal animals. Again, this was quite sur-
prising since many T cells with this specificity that bore
TCRs like those in wild-type animals must have been de-
leted in the 99ATg animals, as exemplified by the disap-
pearance of T cells bearing the transgenic TCRs, AD10 and
AND, in these mice. It is worth noting, however, that the
TCR repertoire of the 99ATg animals was not completely
included within that of normal animals since two different
TCRs which used Vb8.3 were obtained from the 99ATgs,
and IEk 1 MCC–reactive T cells bearing this Vb have not1449 Liu et al.
previously been reported from normal mice, although one
T cell with this specificity and this Vb was reported from
mice heterozygous for Ii expression (15).
Finally, although IEk 1 MCC–reactive T cells bearing
identical TCRs have yet to be independently isolated, these
data support the notion that the complete TCR repertoire
for this MHC 1 peptide combination is nearing saturation.
Several of the chains of the TCRs isolated from our trans-
genic mice were identical in sequence to chains that have been
described previously. Presumably the numbers of TCR a
and b chains that can contribute to TCRs that can react
with IEk 1 MCC are limited, and this fact is reflected in
the fact that particular sequences for a or b are being re-
ported with increased frequency.
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